ALNYLAM NETHERLANDS BV

Italy

All drugs from this manufacturer

  • AMVUTTRA

    Amvuttra is used for the treatment of ATTR amyloidosis, a disease that can be passed down from generation to generation or caused by aging. It works by reducing the amount of a protein called transthyretin (TTR) produced by the liver, thereby helping to reduce the effects of the disease.

    Dosage form: solution for injection in pre-filled syringe

    Active substance Dosage
    vutrisiran -

    ATC: N07XX18

  • GIVLAARI

    It is used for the treatment of acute hepatic porphyria in adults and adolescents aged 12 years and older.

    Dosage form: solution for injection

    Active substance Dosage
    givosiran -

    ATC: A16AX16

  • ONPATTRO

    Onpattro is used for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis), a disease passed from one generation to another caused by problems with the transthyretin (TTR) protein.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    patisiran -

    ATC: N07XX12

  • OXLUMO

    It is used for the treatment of primary hyperoxaluria type 1 (PH1) in adults and children of all ages. This rare disease causes an excess of oxalate in the liver, which can accumulate in the kidneys and damage other organs such as the heart, bones, skin, and eyes.

    Dosage form: solution for injection

    Active substance Dosage
    lumasiran -

    ATC: A16AX18